You're reading the free version. Trader adds the live tape and alerts.
Start tracking
JANX Sale Disclosure
Doyle Janeen Noel · SEC Form 4 · Filed Jun 4, 2026
Sale
Calculated transaction value
$56.94K
Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr
JANX
Janux Therapeutics
JANX
Transaction date
Jun 2, 2026
Public filing date
Jun 4, 2026
Filing lag
Filed 2 days later
JANX daily price context
Close on/before transaction
$13.78
Jun 2, 2026
First close after public filing
$13.36
Jun 5, 2026
30-day return after filing
+15.34%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,059 shares @ $14.03
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002069239-26-000005
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$56.94K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Janux Therapeutics, Inc. JANX Current | Sale | Jun 2, 2026 | $56.94K |